We are pleased to announce that we have been awarded $10.9M from Innovation, Science and Economic Development Canada‘s Life Sciences Fund to advance the development of our technology to expand blood transfusion and organ transplant capabilities by converting the blood type of donor blood and organs to the universal donor type. This investment from the Government of Canada will help drive economic growth, strengthen health resilience and advance Canada’s dual-use industrial capacity.
We are greatly appreciative of this commitment from the Government of Canada to help strengthen Canada’s dual-use life sciences sector.